http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007048097-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fc7a5f1d3a5847194265b272705f1941
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6db1542efe4f0101ccad244019d1a0bb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_096da4619de5c135229a9c628c1958e9
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J1-0011
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J43-003
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56
filingDate 2006-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce01b26e42054584db2c9a9ebba219eb
publicationDate 2010-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2007048097-A3
titleOfInvention Anbrosteeone derivatives and method of use thereof
abstract The disclosure provides androsterone derivatives. The derivatives of the disclosure are useful in the treatment of androgen- and estrogen-associated diseases and disorders,, including breast cancer.
priorityDate 2005-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004106589-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004157262-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005101581-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226616600
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11957461
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5879
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226616599

Total number of triples: 38.